Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyHighmark BlueShield NENY Prior Auth List | OpenPay…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentHighmark Blueshield NenyPolicy N/A

    List of procedures/DME requiring prior authorization

    Customize your policy alerts

    Sign up for all Highmark Blueshield Neny policy alerts

    Know when Highmark Blueshield Neny releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document lists procedures, drugs, and DME that require prior authorization for Highmark BlueShield members in Pennsylvania, West Virginia, and Delaware; it informs providers which codes/modalities may need authorization and plan-specific verification.

    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyList of procedures/DME requiring prior authorization
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateApr 1, 2026
    Next Review DateN/A
    Key ActionVerify member-specific authorization requirements by calling the number on the back of the member's card, checking eligibility via Availity, or searching BlueExchange.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    PA, WV, DEStates referenced
    multipleCodes listed
    manyGold Card Eligible
    multipleOncology J‑codes

    Prior Authorization / Coverage Criteria

    Verification requirement

    Providers must verify member-specific authorization requirements; authorization requirements vary by plan.

    Verify prior authorization requirements for the member before scheduling or performing the service.

    Providers may call the number on the back of the member's card, check eligibility and benefits via Availity, or search BlueExchange through the provider portal.

    Coverage stance for listed cardiac device/imaging codes

    The following cardiac device and cardiac imaging procedure codes and mappings are designated in the authorization list; many are marked Gold Card Eligible.

    Prior authorization is required for the listed cardiac device implantation, replacement, removal, device evaluation, and related cardiac imaging procedures for PA, WV, and DE members.

    Examples of mapped device/imaging entries

    • Codes mapped to 'Cardiac Devices' and marked Gold Card Eligible (examples include mappings of CPT 33224 to 33231/33240/33249/33262/33263/33264/33270 and related HCPCS facility/device codes).
    • Cardiac imaging and CT/SPECT entries cross-mapped to cardiac surgery (examples include CT heart codes 75571-75574, myocardial sympathetic innervation imaging 0331T/0332T mapped to multiple cardiac surgery CPTs).

    Authorization-required procedure listings (partial)

    Partial listing of procedures and mapped codes that require prior authorization for PA, WV, and DE members.

    Procedure examples requiring authorization

    • Placement of extension prosthesis for endovascular repair (initial and additional vessels) including pre-procedure sizing, catheterizations, radiological supervision/interpretation, and treatment zone angioplasty/stenting (mapped to 34709/34710/34711/34712).
    • Percutaneous coronary interventions and intracoronary stent placement (mapped to 92928/92937/92943).
    • Myocardial PET imaging studies including absolute quantitation of myocardial blood flow (AQMBF) (mapped to 78429/78430/78432/78459).
    • Stereotactic implantation of neurostimulator electrode array (first array) (mapped to 61867) where listed.

    Authorization criteria (partial)

    Authorization requirement and program eligibility notes (partial).

    Specified procedures/CPT codes listed in the document require prior authorization for Highmark Managed members.
    Many listed procedures are marked 'Gold Card Eligible,' indicating a streamlined or credentialing-based approval path for certain providers or services.
    The excerpt explicitly references PA, WV, and DE members as the affected populations for these authorization requirements.

    Authorization-required services (partial list)

    Selected service categories and codes from the authorization-required list (partial).

    Selected categories and example codes

    • Coronary angiography/heart catheterization codes (e.g., 93456–93461) are listed as requiring authorization; many are Gold Card Eligible.
    • Heart cath/electrophysiology codes for congenital defects and comprehensive EP evaluations (e.g., 93593–93597, 93653, 93656) require authorization.
    • Home health and training service codes (e.g., G0151–G0156, G0299) require authorization; some entries note 'NOT APPLICABLE TO NY MEDICARE ADVANTAGE MEMBERS.'

    Authorization list (partial)

    Procedures and DME categories listed with authorization requirement and eligibility flags (partial).

    Representative authorization list entries

    • Joint surgery and intraoperative neuromonitoring codes (e.g., 27279–27280, 95940–95941) are listed and may be Gold Card Eligible.
    • MRI/MRA codes across many anatomic sites (e.g., 70545–70549, 72141–72147, 72195–72197) appear on the authorization list, many marked Gold Card Eligible.
    • Hospital beds, accessories and hyperbaric therapy DME (e.g., E0187, E0193, E0295–E0296) require authorization.

    Authorization and designation criteria (nuclear medicine)

    Authorization and designation notes for nuclear medicine procedures in this excerpt.

    Prior authorization is required for the listed nuclear medicine CPT/HCPCS procedures and radiopharmaceutical localization services (multiple codes enumerated in the list).
    Certain nuclear medicine procedures are marked 'Gold Card Eligible' in the list, indicating an alternative authorization pathway for eligible providers or services.

    Scope of nuclear medicine entries

    • Includes thyroid, whole-body, planar and tomographic (SPECT) localization studies and associated CPT/HCPCS codes (examples: 78014, 78016–78020, 78801–78804, 78830–78832).
    • Entries describe tomographic (SPECT) radiopharmaceutical localization studies that may span multiple areas or acquisitions and note associated requirements for imaging (minimum 2 areas or separate acquisitions).

    Authorization listing (partial)

    Partial authorization listing showing nuclear medicine and related entries; some items include effective dates for occupational therapy codes.

    Multiple nuclear medicine and echocardiography/TEE codes are listed as requiring authorization, including tomographic SPECT studies and TEE components.
    Occupational therapy CPTs (97129, 97130, 97168) are included with prior authorization noted for effective date 2/1/2020 where indicated.

    Authorization requirement for listed procedures/injections (partial)

    Procedure 78831 (SPECT radiopharmaceutical localization) and multiple injectable agents are listed as requiring authorization under the Highmark Managed program.

    Procedure 78831 (radiopharmaceutical localization, tomographic SPECT, minimum 2 areas or separate acquisitions) is listed on the authorization schedule and mapped to multiple injectable J‑codes.

    Examples of injectable agents associated with 78831

    • Injectable oncology agents mapped to 78831 include Elranatabmab (J1323), Lanreotide (J1932), Datopotamab deruxtecan (J9011), and others noted in the list; these require authorization when billed in this context.
    • Entries show 78831 paired with example J‑codes and drug names across the Nuclear Medicine = Oncology category.

    Authorization listing (partial)

    Authorization listing (partial) — nuclear medicine tomographic SPECT localization and multiple injectable oncology agents require prior authorization.

    Authorization is required for radiopharmaceutical localization tomographic (SPECT) procedures (minimum 2 areas or separate acquisitions) and for numerous injectable oncology agents listed by J‑code when associated with these procedures.
    Examples of injectable agents include carfilzomib (J9041), bendamustine, and other oncology injections enumerated in the excerpt; these are designated under the Nuclear Medicine = Oncology entries.

    Authorization requirement (partial)

    Partial listing indicating nuclear medicine oncology procedures and listed injections require authorization under Highmark Managed.

    The Nuclear Medicine = Oncology entries list 78831 paired with oncology injectable agents (examples include amivantamab‑VMJW, mirvetuximab soravtansine‑GYNX, calaspargase pegol), and these items are shown as requiring prior authorization for the applicable member populations.

    Prior authorization requirement (partial)

    Prior authorization designation for listed items (partial).

    Items in the list (imaging procedures and injectable agents) are designated 'Highmark Managed,' indicating they require prior authorization per the document.

    Authorization requirement for listed nuclear medicine procedures and injectable oncology drugs

    Portion of the policy showing that listed nuclear medicine procedures and specific injectable oncology agents require authorization under Highmark Managed plans.

    Radiopharmaceutical localization (tomographic SPECT; minimum 2 areas or separate acquisitions) is listed as requiring prior authorization; entries note the imaging may include vascular flow and blood pool imaging when performed.

    Examples of injectable oncology agents requiring authorization

    • Examples enumerated include amivantamab‑VMJW (Rybrevant), mirvetuximab soravtansine‑GYNX (Elahere), and calaspargase pegol‑MKNL (Asparlas).
    • Multiple J‑codes (e.g., J9059, J9061, J9063, J9118) are associated with 78831 in the authorization list and indicate authorization is required when these are billed in the nuclear medicine oncology context.

    Authorization criteria — nuclear medicine / oncology (partial)

    Authorization criteria (partial) — SPECT localization procedure 78831 and associated injectables require prior authorization; coding associations are shown.

    Prior authorization is required for radiopharmaceutical localization SPECT procedures described (tomographic SPECT, minimum 2 areas or separate acquisitions; single‑day or multi‑day imaging) when billed as listed.

    Associated injectables and coding associations

    • Specific injectable agents are listed alongside 78831 (examples: amivantamab‑VMJW [Rybrevant], mirvetuximab soravtansine‑GYNX [Elahere], bendamustine), and these entries require authorization when billed in this context.
    • Procedure 78831 is associated in the list with J‑codes including J9059, J9061, J9063, and J9118 indicating the procedure‑to‑drug coding associations on the authorization schedule.

    Authorization-required items — Nuclear Medicine / Oncology (partial)

    Entries indicate nuclear medicine procedures and associated injectable products that require authorization for Highmark Managed plans; clinical criteria are not provided in these fragments.

    Listed CPT/HCPCS items in the Nuclear Medicine / Oncology section (including 78831 and associated J‑codes) are flagged for prior authorization under Highmark Managed.

    Codes and Code Mappings

    Applied Behavioral Analysis and related mental health codesCPT | HCPCSCovered
    97151Behavior identification assessment used for initial or reassessment and treatment plan development
    97152Behavior identification supporting assessment
    97154Group adaptive behavior treatment by protocol, administered by a technician
    97155Adaptive behavior treatment protocol modification
    97156Family adaptive behavior treatment guidance
    97157Multiple-family group adaptive behavior treatment guidance
    97158Group adaptive behavior treatment with protocol modification
    0362TAdaptive behavior assessment with technician assistance, each 15 minutes
    0373TAdaptive behavior treatment with protocol modification
    H0032Mental health service plan development by non-physician
    1–10 of 11
    1/2
    Cardiac device and capsule endoscopy codesCPT | HCPCSCovered
    91110Capsule endoscopy, GI tract imaging with interpretation and report
    91111Capsule endoscopy, GI tract imaging
    33206Insertion/replacement of permanent pacemaker with lead(s)
    33207Insertion/replacement of permanent pacemaker with lead(s)
    33208Insertion of permanent pacemaker with transvenous electrodes; atrial and ventricular
    33214Revision/replacement of pacemaker system (dual chamber)
    33216Insertion of new pulse generator; single transvenous electrode
    33217Insertion of 2 transvenous electrodes
    33224Insertion of pacing electrode, cardiac venous system, for LV pacing (multiple related entries)
    Bariatric surgery codesCPTCovered
    43644Laparoscopy, surgical, gastric restrictive procedure with gastric bypass and Roux-en-Y
    43645Laparoscopy, gastric restrictive procedure with small intestine reconstruction
    43647Laparoscopy; implantation/replacement of gastric neurostimulator electrodes
    43770Placement of adjustable gastric restrictive device (gastric band)
    43771Revision of adjustable gastric restrictive device component only
    43772Removal of adjustable gastric restrictive device component only
    43773Removal and replacement of adjustable gastric restrictive device component
    43774Removal of adjustable gastric restrictive device and subcutaneous port components
    43775Longitudinal gastrectomy (sleeve gastrectomy)
    43842Gastric restrictive procedure without gastric bypass for morbid obesity
    1–10 of 15
    1/2
    Cardiac device and cardiac imaging codes mapped in excerptmixed
    33224Insertion of pacing electrode, cardiac venous system, for left ventricular pacing, with attachment to previously placed pacemaker or ICD pulse generator (including revision of pocket, removal, insertion, and/or replacement of existing generator)
    33231Removal of permanent pacemaker pulse generator with replacement; multiple lead system (mapped in doc)
    33240Insertion of implantable defibrillator pulse generator only; with existing multiple leads (mapped)
    33249Insertion or replacement of permanent implantable defibrillator system with transvenous lead(s), single or dual chamber (mapped)
    33262Removal of implantable defibrillator pulse generator with replacement; single lead system (mapped)
    33263Removal of implantable defibrillator pulse generator with replacement; single lead system (alternate mapping)
    33264Removal of implantable defibrillator pulse generator with replacement; dual lead system (mapped)
    33270Removal of implantable defibrillator pulse generator with replacement; multiple lead system (mapped)
    33273Defibrillation threshold evaluation and device programming when performed (mapped)
    33274Repositioning of previously implanted subcutaneous ICD electrode (mapped)
    1–10 of 49
    1/5
    Endovascular repair / extension prosthesis mappingsmixed
    34710Highmark mapping for 0332T (placement of extension prosthesis / initial vessel)
    34711Highmark mapping for 0332T (additional vessel)
    34712Highmark mapping for 0332T (transcatheter delivery of enhanced fixation device)
    Coronary intervention CPT mappingsCPT
    92928Percutaneous transluminal coronary angioplasty; single major coronary artery or branch
    92937Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty; single major coronary artery or branch
    92943Percutaneous transluminal revascularization of or through coronary artery bypass graft; single vessel
    Cochlear device HCPCS mappingsHCPCS
    L8614Cochlear device component code (noted in mapping)
    L8619Cochlear device includes all internal and external components
    Myocardial PET CPT mappingsCPT
    78429Myocardial PET metabolic imaging (listed/mapped)
    78430Myocardial PET perfusion with concurrently acquired CT transmission scan
    78432Myocardial PET multiple studies at rest and stress with CT
    78459Absolute quantitation of myocardial blood flow (AQMBF), PET rest and pharmacologic stress
    Neurosurgical and imaging CPT mappingsCPT
    61863Twist drill, burr hole, craniotomy with stereotactic implantation (mapped)
    61867Stereotactic implantation of neurostimulator electrode array (mapped)
    70450CT head (noted in mapping)
    70460CT head with contrast (noted in mapping)
    Sample CPT/HCPCS codes presentCPT
    70460CT head without contrast (mapped in list)
    70470CT head with contrast (mapped in list)
    72125CT cervical spine without contrast (appears in list)
    74263CT colonography (screening) (appears in list)
    93350Echo for congenital cardiac anomalies / imaging add-on (appears in list)
    65771Eye surgery code listed (radial keratotomy/PRK related)
    93451Right heart catheterization (appears in list)
    Coronary angiography / heart cath codesCPTCovered
    93456Catheter placement in coronary artery(s) for coronary angiography
    93457with right heart catheterization
    93458with catheter placement(s) in bypass graft(s)
    93459with left heart catheterization including ventriculography
    93460with bypass graft angiography
    93461with right and left heart catheterization
    Home health and DME examplesmixedCovered
    G0151Home health physical therapy services, each 15 minutes
    G0152Home health occupational therapy services, each 15 minutes
    G0153Home health speech-language pathology services, each 15 minutes
    E0187Water pressure mattress
    E0193Powered air flotation bed (low air loss therapy)
    Selected MRI/MRA codesCPTCovered
    70545MRA head without contrast
    70546MRA head with contrast
    70547MRA head with & without contrast / MRA neck without contrast
    70549MRA neck with & without contrast
    72141MRI chest without contrast
    72142MRI chest with contrast
    72146MRI cervical spine without contrast
    72147MRI cervical spine with contrast
    Neurostimulator and accessory codesCPTCovered
    61885Insertion or replacement of cranial neurostimulator pulse generator
    63663Revision/replacement of spinal neurostimulator percutaneous electrode array
    64561Revision including replacement of spinal neurostimulator electrode plate/paddle(s)
    64581Open implantation of neurostimulator electrode array; sacral nerve
    64582Open implantation of hypoglossal nerve neurostimulator array
    64590Insertion or replacement of peripheral or gastric neurostimulator pulse generator
    L8695Accessories, external recharging system for implantable neurostimulator
    Selected fetal MRI, MRI spectroscopy, and nuclear medicine codesCPTCovered
    74712Magnetic resonance imaging, fetal, single/first gestation
    74713Magnetic resonance imaging, fetal, each additional gestation
    76390MRI spectroscopy
    77021Unlisted MRI procedure / guidance for needle placement
    78012Thyroid uptake, quantitative
    78014Thyroid imaging (including vascular flow)
    78016Thyroid/met imaging
    78018Thyroid met imaging with additional studies
    Nuclear medicine CPT/HCPCS codes referencedCPT
    78020General nuclear medicine series reference code used throughout this section
    78830Tomographic (SPECT) with concurrently acquired CT for localization
    78999Unlisted procedure, diagnostic nuclear medicine - radiation therapy
    Nuclear medicine SPECT groupingCPTCovered
    78831Referenced/paired with 78832 or used in nuclear medicine SPECT multi-area studies
    Unlisted nuclear medicine mappingCPT
    78999Unlisted procedure, diagnostic nuclear medicine - radiation therapy (mapped from an entry)
    Echocardiography / TEE codesCPTCovered
    93312Treatment planning TEE 2D; includes probe placement, imaging/interpretation/report
    93313TEE placement of probe only
    93314TEE image acquisition, interpretation and report only
    93315Transesophageal echocardiography for congenital cardiac anomalies; full service
    93316TEE for congenital anomalies; probe placement only
    93317TEE image acquisition, interpretation and report only for congenital anomalies
    Contrast echocardiography and add-on codesCPTCovered
    0439TMyocardial contrast perfusion echocardiography (list separately)
    C8926TEE with contrast (for congenital anomalies)
    Occupational therapy CPTsCPTCovered
    97129Therapeutic interventions focusing on cognitive function; initial 15 minutes
    97130Each additional 15 minutes (add-on)
    97168Re-evaluation of occupational therapy
    Oncology injectable J-codesHCPCSCovered
    J1323Injection, Elranatabmab-BCMM, 1 mg (ELREXFIO)
    J1326Injection, Zolbetuximab-clzb, 2 mg (VYLOY)
    J1448Injection, Trilaciclib, 1 mg (COSELA)
    J1932Injection, Lanreotide (CIPLA), 1 mg
    J1950Leuprolide acetate (for depot suspension), per 3.75 mg
    Procedure-to-Jcode mappings (partial)CPT | HCPCS
    78831Tomographic (SPECT) radiopharmaceutical localization, minimum 2 areas
    J1932Injection, lanreotide (example mapping in excerpt)
    J1950Injection, leuprolide acetate (per 3.75 mg) (appears mapped)
    Additional J‑codes in excerptHCPCS
    J9011Datopotamab deruxtecan-dlnk (DATROWAY) — listed as injection
    J9039Blinatumomab (BLINCYTO) — listed as injection
    J9041Carfilzomib (KYPROLIS) — listed as injection
    Nuclear medicine procedure and injectable oncology J-codesCPT | HCPCS | mixedCovered
    78831Nuclear medicine procedure; radiopharmaceutical localization (SPECT), minimum 2 areas or separate acquisitions
    J9041Carfilzomib 0.1 mg (example listed)
    J9047Referenced injection code in list
    J9048Referenced injection code in list
    J9049Referenced injection code in list
    J9051Referenced injection code in list
    J9054Referenced injection code in list
    J9055Referenced injection code in list
    J9056Referenced injection code in list
    J9058Referenced injection code in list
    1–10 of 14
    1/2
    Nuclear medicine SPECT procedureCPT
    78831Tomographic (SPECT) radiopharmaceutical localization, minimum 2 areas or separate acquisitions
    Referenced J-codes for injectable oncology agentsHCPCS
    J9061
    J9063
    J9118
    SPECT radiopharmaceutical mappingCPT | HCPCS | mixed
    78831Tomographic (SPECT) radiopharmaceutical localization, as listed; mapping referenced to J-codes
    J9061Referenced J-code in mapping
    J9063Referenced J-code in mapping
    J9118Referenced J-code in mapping
    Named injectable productsHCPCS
    Amivantamab-vmjw injection, 2 mg (Rybrevant) — listed as requiring authorization
    Mirvetuximab soravtansine-gynx injection, 1 mg (Elahere) — listed as requiring authorization
    Calaspargase pegol-mknl, 10 units (Asparlas) — listed as requiring authorization
    Nuclear medicine / oncology injectable codesmixed
    78831Nuclear medicine tomographic (SPECT), minimum 2 areas or separate acquisitions
    J9059HCPCS J‑code shown in this section
    J9061HCPCS J‑code shown in this section
    J9063HCPCS J‑code shown in this section
    J9118HCPCS J‑code shown in this section
    Nuclear medicine / oncology procedure and associated J-codesmixed
    78831Nuclear medicine procedure (referenced)
    J9059
    J9061
    J9063
    J9118
    Nuclear medicine — oncologymixed
    78831Tomographic (SPECT) radiopharmaceutical localization, minimum 2 areas or separate acquisitions
    J9059
    J9061
    J9063
    inv-48: Gold Card eligibility
    DefinitionSome listed CPT/HCPCS items are flagged 'Gold Card Eligible' indicating they are eligible for Highmark's Gold Card expedited authorization process where indicated.
    ScopeApplies to CPT/HCPCS items shown in the authorization list for PA, WV, and DE members (examples: bariatric, cardiac device entries).
    Operational note'Gold Card Eligible' appears alongside specific code mappings in the list but the document fragment does not define operational criteria for Gold Card enrollment.
    inv-49: Gold Card Eligible flag
    Flag meaningThe 'Gold Card Eligible' flag marks services in the authorization list that may qualify for a streamlined or credentialing‑based authorization pathway.
    Where shownUsed throughout imaging and procedure sections (e.g., CT/MRA/MRI, echo entries) to mark eligible services.
    Provider implicationPresence of the flag indicates potential expedited handling but providers must still verify member‑specific authorization requirements.

    What Providers Must Do

    Prior Authorization

    Verify Authorization Requirements

    For PA, WV, & DE Members — How to verify authorization requirements: Providers must obtain prior authorization where indicated on the Highmark list. To verify a member’s specific authorization requirements, providers may: 1) call the number on the back of the member’s ID card; 2) check eligibility and benefits via Availity; or 3) search BlueExchange® through the provider’s local payer portal.

    • Applies to Highmark BlueShield NENY members effective 2026-04-01.
    • Authorization requirements vary by benefit plan — always verify for the specific member prior to scheduling.
    Prior Authorization

    Cardiac Device & Related Procedures – Prior Authorization Required

    Prior authorization is required for listed cardiac device implantation, replacement, removal, device evaluation, and related procedures. Providers must obtain authorization per this policy before performing these services.

    • Includes pacemaker and implantable cardioverter-defibrillator (ICD) generator insertion/replacement/removal and left ventricular pacing lead procedures (e.g., CPT 33224, 33231, 33240, 33249, 33262–33270 series as listed).
    • Many cardiac device items are Gold Card Eligible for Highmark Managed members; confirm applicability per member plan.
    Prior Authorization

    Endovascular Repair — Extension Prosthesis (Initial Vessel)

    Endovascular repair — extension prosthesis placement (initial vessel) requires prior authorization when listed.

    • Procedure examples include placement of extension prosthesis distal to common iliac or proximal to renal arteries; list initial vessel separately in addition to primary procedure code.
    Prior Authorization

    Endovascular Repair — Extension Prosthesis (Additional Vessel)

    Endovascular repair — extension prosthesis placement for each additional vessel requires prior authorization when listed.

    • List each additional vessel treated separately in addition to the code for the primary procedure.
    Prior Authorization

    Endograft Enhanced Fixation Device Delivery

    Transcatheter delivery of endograft enhanced fixation devices (anchors, screws, tacks) requires prior authorization when listed.

    • Authorization applies to delivery/placement of enhanced fixation device(s) to the endograft and associated radiological supervision/interpretation.
    Prior Authorization

    PCI and Intracoronary Stent Placement

    Percutaneous coronary interventions (PCI) and intracoronary stent placement require prior authorization when listed on the authorization list.

    • Includes percutaneous transluminal coronary angioplasty and intracoronary stent placement codes (examples referenced in the list).
    • Many PCI/stent items are Gold Card Eligible for Highmark Managed members; verify member-specific rules.
    Prior Authorization

    Transcatheter Closure of Interatrial Communication

    Transcatheter closure of interatrial communications (e.g., ASD, Fontan fenestration) requires prior authorization when listed.

    • Example procedure: percutaneous transcatheter closure of congenital interatrial communication with implant (listed as Gold Card Eligible where indicated).
    • Providers must obtain authorization before performing transcatheter closure procedures.
    Prior Authorization

    Cardiac Contractility Modulation System Insertion/Replacement

    Cardiac contractility modulation system insertion/replacement procedures require prior authorization when listed.

    • Includes insertion or replacement of permanent cardiac contractility modulation system (pulse generator with transvenous electrodes) and associated evaluation/programming (listed codes such as 0409T/0408T equivalents).
    Prior Authorization

    Cataract Removal with Aqueous Drainage Device Insertion

    Cataract removal with insertion of an anterior segment aqueous drainage device (internal, without extraocular reservoir) requires prior authorization when listed.

    • Includes extracapsular cataract removal with intraocular lens insertion plus anterior segment aqueous drainage device (CPT 66989 and related codes).
    • Many of these entries are marked Gold Card Eligible for Highmark Managed members — verify member eligibility.
    Prior Authorization

    Cochlear Device Implantation and Components

    Cochlear implant procedures and device components require prior authorization when listed.

    • Includes cochlear device implantation with or without mastoidectomy (CPT 69714, 69930) and internal/external component codes (HCPCS L8614, L8619).
    • Authorization required for implant and often for associated device component billing; confirm device code coverage and member plan applicability.
    Prior Authorization

    Myocardial PET Imaging (Perfusion/Metabolic/AQMBF)

    Myocardial PET imaging (perfusion, metabolic, and Absolute Quantitation of Myocardial Blood Flow — AQMBF) requires prior authorization when listed.

    • Includes PET myocardial blood flow absolute quantitation (AQMBF), PET metabolic evaluation, and PET perfusion studies (examples CPT 78459, 78491, 78492 and related descriptors).
    • Obtain authorization for rest and pharmacologic stress studies and for multiple-study protocols as listed.
    Prior Authorization

    Coronary Angiography / Heart Catheterization

    Coronary angiography / heart catheterization and related procedures require prior authorization when listed on the Highmark authorization list.

    • Examples include catheter placement in coronary arteries for coronary angiography with right heart catheterization (CPT 93456) and related left/right heart catheterization codes (CPT 93457, 93458, 93593–93597 series).
    • Many heart cath items are Gold Card Eligible for Highmark Managed members; verify per-member requirements.
    Prior Authorization

    Heart Cath / Electrophysiology Procedures

    Heart catheterization and electrophysiology procedures (diagnostic and ablation) require prior authorization when listed.

    • Includes comprehensive electrophysiologic evaluation with catheter insertion and ablation (e.g., CPT 93653) and other EP procedure codes listed.
    • Obtain authorization before scheduling electrophysiology procedures.
    Prior Authorization

    Home Health Services / Training

    Home health services and home care training require prior authorization when listed.

    • Covered codes include G0151–G0156 (home health therapy services), G0299, G0300, and home care training codes S5108–S5116 (note: some S-codes are not applicable to NY Medicare Advantage members).
    • Verify member-specific applicability and obtain authorization as required.
    Prior Authorization

    Hospital Beds, Accessories, Hyperbaric Therapy

    Hospital beds, accessories, and hyperbaric therapy items require prior authorization when listed.

    • DME codes include E0197, E0198 (air/water pressure pads), E0295–E0316 (hospital bed models and accessories).
    • Hyperbaric therapy codes include 99183 and G0277 — these are noted as Gold Card Eligible in some cases.
    Prior Authorization

    Hysterectomy and Inpatient Detoxification Services

    Hysterectomy procedures and inpatient detoxification/rehabilitation services require prior authorization when listed.

    • Hysterectomy CPT examples include 51597, 58150, 58152, 58180, 58210, 58260, and the laparoscopic hysterectomy series (58541, 58543, 58548, 58550–58575).
    • Inpatient detoxification/rehabilitation codes (H0008–H0011) require authorization when indicated.
    Prior Authorization

    Intraoperative Monitoring, Joint Surgery, Listening Devices, MRI/MRA

    Intraoperative neurophysiologic monitoring, certain joint surgery, assistive listening devices, and MRI/MRA studies require prior authorization when listed.

    • Intraoperative monitoring codes: 95940, 95941, G0453. Joint surgery examples: 27279, 27280. Assistive listening device codes: V5281, V5282. MRA/MRI examples: 70545–70549, 71555, 72159 series — many marked Gold Card Eligible for Highmark Managed members.
    • Obtain authorization for intraoperative monitoring billed in addition to the primary procedure.
    Note

    List Requiring Authorization (Partial)

    This section is a partial representation of the Highmark list of procedures and DME that require prior authorization. Providers must consult the full Highmark authorization list for complete code-level details and any Gold Card eligibility notes.

    • The full list includes a broad range of imaging, procedures, DME, home health, and drug injection items effective 04/01/2026.
    • Gold Card Eligible entries may be exempted for certain providers/members — verify via eligibility tools prior to ordering.
    Prior Authorization

    Prior Authorization — Nuclear Medicine Procedures and Injectable Oncology Agents

    Prior authorization is required for the nuclear medicine procedures and associated injectable oncology agents listed. Radiopharmaceutical localization SPECT procedures (tomographic SPECT, minimum two areas or separate acquisitions) require authorization when billed as listed.

    • Example nuclear medicine procedure group: radiopharmaceutical localization of tumor/inflammatory process by tomographic SPECT (CPT 78831 mapped to multiple codes in the list).
    • Authorization required for myocardial SPECT, thyroid imaging, whole-body scans and other nuclear medicine services as specified.
    Prior Authorization

    Drug Injection Codes Requiring Authorization (Partial)

    Certain drug injection / J-code items associated with nuclear medicine oncology procedures require prior authorization when listed.

    • Examples of associated J-codes and HCPCS listed: J9058, J9059, J9061, J9063, J9118, J1323, J1326, J1448, J1932, J1950 and others appearing in the oncology injectables portion of the list.
    • Specific injectable agents referenced include amivantamab (Rybrevant), mirvetuximab soravtansine (Elahere), calaspargase pegol (Asparlas), elranatamab (Elrexfio), zolbetuximab (Vyloy), trilaciclib (Cosela), and leuprolide depot formulations.
    Prior Authorization

    Associated Drug J‑Codes and Injectable Oncology Agents

    Associated drug J‑codes and oncology injectable agents tied to nuclear medicine and oncology services are included in the authorization requirements and must be authorized when listed.

    • Multiple entries map CPT/HCPCS nuclear medicine procedure codes (e.g., 78831) to specific J-codes — confirm both the imaging procedure and the injectable agent require authorization.
    • When a radiopharmaceutical localization study includes an associated injectable listed by J-code, obtain authorization for both the imaging and the drug as applicable.
    Prior Authorization

    Prior Authorization Required — Nuclear Medicine Oncology Procedures/Injectables

    Prior authorization is required for nuclear medicine oncology procedures and injectables listed on the Highmark authorization list effective 04/01/2026.

    • Examples: radiopharmaceutical localization SPECT procedures billed with associated J-codes (J9059, J9061, J9063, J9118, and related codes) require authorization.
    • Providers must obtain authorization for both imaging (e.g., SPECT localization) and the specified injectable oncology agents when both are listed.

    Definitions and Flags

    inv-88: NOC — definition note
    TermNOC
    ContextUsed in modality/code fields for oncology or specialty drug entries (appears as 'NOC' in the list).
    Applies toEntries describing drugs or specialty items where code is listed as NOC in the document fragment.
    inv-89: Gold Card Eligible — definition and explanation of the flag
    TermGold Card Eligible
    DefinitionDesignation used in the authorization list to flag procedures/services that may be eligible for Gold Card (expedited) processing in Highmark Managed listings.
    LimitationsThe fragment shows the designation but does not provide operational enrollment or approval criteria within these chunks.
    inv-90: Gold Card Eligible — policy designation used alongside procedure mappings
    Usage'Gold Card Eligible' is applied alongside specific procedure/code mappings (e.g., cardiac device and imaging mappings) within the policy's code list.
    ExamplesAppears with Cardiac Devices/Cardiac Imaging entries such as 33224 mapped entries and related device codes.
    Document roleServes as a policy designation visible in procedure-to-code mappings to indicate potential expedited pathway for eligible providers/services.
    inv-91: Cardiac Devices / Cardiac Imaging — service category definition
    CategoryCardiac Devices / Cardiac Imaging
    DefinitionService categories assigned to listed procedures and codes (device implantation, replacement, device evaluation, and cardiac imaging studies) within the document excerpt.
    ExamplesIncludes pacemaker/ICD insertion/replacement (33206–33224 series), device evaluation/interrogation, and myocardial PET imaging (AQMBF entries).
    inv-92: Gold Card Eligible — designation used in fragment to indicate certain procedures eligible for Gold Card program
    Designation useThe 'Gold Card Eligible' label is used in fragments to mark certain listed procedures as eligible for the Gold Card program.
    Locations in listSeen across cardiac, imaging, and nuclear medicine sections of the authorization list.
    Action for providersEven when marked Gold Card Eligible, providers must verify member-specific authorization requirements before performing services.
    inv-93: AQMBF — Absolute Quantitation of Myocardial Blood Flow (PET) definition
    TermAQMBF (Absolute Quantitation of Myocardial Blood Flow)
    DefinitionA PET myocardial imaging procedure for absolute quantitation of myocardial blood flow, listed separately in addition to primary PET procedure codes.
    Example code mappingMapped to PET myocardial imaging entries (e.g., 78459) and shown with Gold Card Eligible status in the list.
    inv-94: Gold Card Eligible — repeated flag in list
    Repeated flag'Gold Card Eligible' appears repeatedly throughout the authorization list to mark eligible services.
    ImplicationIndicates potential expedited authorization handling for flagged entries; providers still must verify plan requirements.
    Sections where repeatedCommon in imaging (CT/MRI/MRA), cardiac device, and nuclear medicine entries in the document fragment.
    inv-95: 93350 usage note — echo add-on code note
    Code93350
    Usage noteListed as an add-on echo code for congenital cardiac anomalies; to be listed separately in addition to the primary echocardiography code when performed.
    Provider actionWhen billing, list 93350 in addition to the primary echo code for congenital anomaly assessment per document note.
    inv-96: Gold Card Eligible — repeated
    Flag recurrence'Gold Card Eligible' is repeatedly applied to entries in the authorization list to denote potential eligibility for Gold Card processing.
    Affected areasNoted repeatedly in MRI/MRA, CT, cardiac, and nuclear medicine sections.
    Verification reminderProviders should confirm member-specific authorization rules even for Gold Card flagged items.
    inv-97: NY Medicare Advantage exception — NOT APPLICABLE TO NY MEDICARE ADVANTAGE MEMBERS
    StatementNOT APPLICABLE TO NY MEDICARE ADVANTAGE MEMBERS
    ContextAppears in home health training/service code entries indicating these specific items do not apply to NY Medicare Advantage populations.
    Affected codesExamples include home care training codes S5108–S5116 where the note is applied.
    inv-98: Gold Card Eligible — usage in MRI/MRA entries
    Usage in MRI/MRA'Gold Card Eligible' is used to flag many MRI/MRA entries (e.g., 70545–70549, 71555) in the authorization list.
    ImplicationFlag suggests potential streamlined authorization for these imaging services for eligible providers.
    Provider requirementProviders must still verify member benefits and authorization requirements despite the flag.
    inv-99: Highmark Managed — definition of label used throughout the list
    TermHighmark Managed
    DefinitionLabel used throughout the list to indicate items subject to Highmark's managed authorization program (entries require prior authorization as indicated).
    AppearancesPrecedes many service entries and code mappings across the document (CT, MRI, nuclear medicine, device procedures).
    inv-100: Gold Card Eligible — repeated
    Designation recurrence'Gold Card Eligible' appears multiple times in nuclear medicine and oncology procedure entries within the fragment.
    Document roleMarks specific nuclear medicine SPECT and related injection mappings as potentially eligible for expedited processing.
    Provider noteEven when nuclear oncology items are Gold Card Eligible, prior authorization is listed as required in these entries.
    inv-101: Nuclear Medicine — definition/label
    TermNuclear Medicine
    DefinitionCategory heading used in the authorization list for nuclear imaging procedures and related CPT/HCPCS codes.
    ExamplesIncludes thyroid imaging (78014–78075), SPECT studies (78830–78832), and multiple other nuclear medicine CPTs listed in the fragment.
    inv-102: RADIOPHARMACEUTICAL LOCALIZATION OF TUMOR/INFLAMMATORY PROCESS (SPECT) — definition
    ProcedureRADIOPHARMACEUTICAL LOCALIZATION OF TUMOR/INFLAMMATORY PROCESS (SPECT)
    DefinitionTomographic (SPECT) radiopharmaceutical localization of tumor, inflammatory process, or distribution of radiopharmaceutical agent(s); includes vascular flow and blood pool imaging when performed; minimum 2 areas or separate acquisitions, single‑day imaging or multi‑day acquisitions.
    Associated procedure codeCommonly referenced as CPT 78831 (SPECT radiopharmaceutical localization) in the document fragment.
    inv-103: TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE) — definition
    TermTRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE)
    DefinitionTransesophageal echocardiography (TEE) — includes probe placement, image acquisition, interpretation and report; components may be listed separately (probe placement, image acquisition/interpretation).
    Mapping noteTEE codes (93312–93317) appear in the authorization list and may be marked Gold Card Eligible where indicated.
    inv-104: 78831 / SPECT radiopharmaceutical localization — definition
    Code78831
    Definition78831 is listed as the SPECT radiopharmaceutical localization procedure; document maps 78831 to example injectables (e.g., J1932, J9059, J9061, J9063, J9118) in oncology context.
    Usage78831 entries describe tomographic SPECT localization of tumor/inflammatory processes with minimum 2 areas or separate acquisitions and are listed as requiring authorization.
    inv-105: SPECT radiopharmaceutical localization (minimum 2 areas / separate acquisitions) — definition
    Procedure requirementRadiopharmaceutical localization (SPECT) — tomographic studies require minimum 2 areas or separate acquisitions; single‑day imaging or multi‑day acquisitions are included.
    ScopeDescribed as localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s), including vascular flow and blood pool imaging when performed.
    AuthorizationThese SPECT localization procedures are listed as requiring prior authorization in the document fragment.
    inv-106: RADIOPHARMACEUTICAL LOCALIZATION (SPECT) — definition
    TermRADIOPHARMACEUTICAL LOCALIZATION (SPECT)
    DefinitionTomographic (SPECT) radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s); minimum 2 areas or separate acquisitions; single‑day or multi‑day imaging options described in entries.
    Associated codesDocument references 78831 and related mappings to J‑codes for injectable agents in oncology context.
    inv-107: RADIOPHARMACEUTICAL LOCALIZATION OF TUMOR/INFLAMMATORY PROCESS (SPECT) — definition
    TermRADIOPHARMACEUTICAL LOCALIZATION OF TUMOR/INFLAMMATORY PROCESS (SPECT)
    DescriptionLocalization includes vascular flow and blood pool imaging when performed; tomographic (SPECT) studies across multiple areas or separate acquisitions as listed in the policy fragment.
    ExamplesEntries pair the SPECT procedure with injectable oncology agents (e.g., amivantamab, mirvetuximab, bendamustine) and associated J‑codes.
    inv-108: Radiopharmaceutical localization (SPECT) — definition
    TermRadiopharmaceutical localization (SPECT)
    DefinitionLocalization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s), including vascular flow and blood pool imaging; tomographic SPECT studies with minimum 2 areas or separate acquisitions as described in the list.
    Billing implicationProcedure entries are listed with associated injectable agents/J‑codes and require prior authorization per the document fragment.
    inv-109: Radio­pharmaceutical localization (SPECT) — definition
    TermRadio­pharmaceutical localization (SPECT)
    DefinitionTomographic (SPECT) radiopharmaceutical localization of tumor/inflammatory process or agent distribution; includes vascular flow and blood pool imaging when performed, minimum 2 areas or separate acquisitions, single‑day or multi‑day acquisitions.
    Associated itemsDocument pairs these procedures with injectable oncology agents and lists J‑codes (e.g., J9059, J9061, J9063, J9118) as associated billing items.
    inv-110: RADIOPHARMACEUTICAL LOCALIZATION (SPECT) description
    DescriptionRadiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) includes vascular flow and blood pool imaging when performed; tomographic (SPECT) minimum 2 areas or separate acquisitions, single‑day or multi‑day acquisitions.
    Procedure codeCPT 78831 is used to represent SPECT radiopharmaceutical localization in multiple entries.
    Associated injectablesEntries list multiple injectable oncology agents (mapped by J‑code) associated with these procedures and require prior authorization.
    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyList of procedures/DME requiring prior authorization
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateApr 1, 2026
    Next Review DateN/A
    Key ActionVerify member-specific authorization requirements by calling the number on the back of the member's card, checking eligibility via Availity, or searching BlueExchange.
    SourceLink
    On This Page
    Prior Authorization / Coverage CriteriaCodes and Code MappingsWhat Providers Must DoDefinitions and Flags